Method for manufacturing a shaped cross-linked hyaluronic acid product
A method for manufacturing a shaped cross-linked hyaluronic acid product including the step of subjecting a non-cross-linked precipitated hyaluronic acid substrate in a desired shape to a single cross-linking reaction in a liquid medium having a pH of 11.5 or higher and including one or more polyfunctional cross-linking agent(s) and an amount of one or more organic solvent(s) giving precipitating conditions for hyaluronic acid, under suitable conditions to obtain a precipitated, shaped cross-linked hyaluronic acid product having a degree of modification of 1-40 cross-linking agent units per 1000 disaccharide units.
1. A hydrogel product with a longitudinal extension of greater than 2 mm, the product comprising multiple layers of hyaluronic acid (HA) and an external layer of crosslinked HA, wherein the hydrogel comprises an internal layer of crosslinked HA that exhibits a different degree of modification than the external layer.
2. The product according to claim 1 , wherein the internal layer of crosslinked HA exhibits a lower degree of modification than the external layer.
3. The product according to claim 1 , wherein one or more of the multiple layers is formed by extrusion.
4. The product according to claim 1 , wherein the longitudinal extension is greater than 25 mm.
5. The product according to claim 1 , wherein the longitudinal extension is greater than 500 mm.
6. The product according to claim 1 , wherein the longitudinal extension is less than 5 mm.
7. The product according to claim 1 , wherein the hydrogel has a diameter from 0.1 to 2 mm.
8. The product according to claim 1 , wherein the hydrogel has a diameter less than 1 mm.
9. The product according to claim 1 , wherein the HA is of non-animal origin.
10. The product according to claim 1 , wherein the hydrogel is a string.
11. The product according to claim 10 , wherein the string is woven together to form a net.
12. The product according to claim 11 , wherein the net is greater than 5 mm in at least one dimension.
13. A composition comprising the product according to claim 1 .
14. The composition according to claim 13 , wherein the composition is sterile.
15. The composition according to claim 13 , further comprising a buffering agent.
16. The composition according to claim 13 , further comprising one or more drugs.
17. The composition according to claim 16 , wherein the one or more drugs are selected from the group consisting of: an anesthetic, an anti-inflammatory agent, an antibiotic, and a growth factor.
18. The composition according to claim 13 , further comprising one or more proteins.
19. The composition according to claim 13 , further comprising one or more cells.
20. The composition according to claim 19 , wherein the one or more cells are human cells.
21. A composition comprising a plurality of hydrogel products with a longitudinal extension of greater than 2 mm, wherein the hydrogel products comprise multiple layers of hyaluronic acid (HA) and an external layer of crosslinked HA.
22. The composition according to claim 21 , wherein at least 50% of the hydrogel products have a lateral extension of less than 0.2 mm.